Studies raise concerns that taking anemia drugs after chemo may be harmful

02/27/2007 | NYTimes.com

Anemia drugs sold by Amgen, Johnson & Johnson and Roche could be harming some cancer patients instead of helping them, new studies conclude. The drugs are used to treat anemia that results from chemotherapy, but the studies suggest use of those drugs for that purpose may make the cancer worse. Amgen said its anemia drug was safe and effective when used as intended.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID